PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.72
ESG score 80-90% of ADAP's 68.49. Walter Schloss would scrutinize governance quality and regulatory exposure.
58.63
Environmental score 80-90% of ADAP's 66.27. Walter Schloss would scrutinize carbon exposure and transition planning.
59.61
Social score 90-95% of ADAP's 65.69. Bill Ackman would demand clear social improvement catalysts.
60.92
Governance score 80-90% of ADAP's 73.52. Walter Schloss would scrutinize management accountability and board independence.